Expression of proliferation marker Ki67 correlates to occurrence of metastasis and prognosis, histological subtypes and HPV DNA detection in penile carcinomas

Histology and Histopathology

Volumn 22, Issue 10-12, 2007, Pages 1197-1204

  Protzel, Chris ^a   Knoedel, J ^b   Zimmermann, U ^a   Woenckhaus, C ^c   Poetsch, M ^a   Giebel, J ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b HELIOS KLINIKEN SCHWERIN   (Germany)

^c Institute of Pathology   (Germany)

Author keywords

HPV; Ki67; Metastasis; Penile carcinoma

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; PARAFFIN; VIRUS DNA; TUMOR MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CORRELATIONAL STUDY; DNA DETERMINATION; DNA ISOLATION; EMBEDDING; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; METASTASIS POTENTIAL; NONHUMAN; PENIS AMPUTATION; PENIS CARCINOMA; POLYMERASE CHAIN REACTION; PROGNOSIS; SQUAMOUS CELL CARCINOMA; VIRUS DETECTION; ADENOCARCINOMA; ALPHAPAPILLOMAVIRUS; DISEASE FREE SURVIVAL; ENZYME IMMUNOASSAY; GENETICS; ISOLATION AND PURIFICATION; LYMPH NODE; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PENIS TUMOR; VIROLOGY; VIRUS INFECTION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; DISEASE-FREE SURVIVAL; DNA, VIRAL; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PENILE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34748919538     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Berdjis N., Meye A., Nippgen J., Dittert D., Hakenberg O., Baretton GB. and Wirth M.P. (2005). Expression of Ki67 in squamous cell carcinoma of the penis. BJU Int. 96, 146-148.
2. Burkhart B.A., Alcorta D.A., Chiao C., Isaacs J.S. and Barrett J.C. (1999). Two posttranscriptional pathways that regulate p21(Cip1/Waf1/ Sdi1) are identified by HPV16-E6 interaction and correlate with life span and cellular senescence. Exp. Cell Res. 25, 247, 168-175.
3. Cubilla A. L., Meijer C.J. and Young R.H. (2000). Morphological features of epithelial abnormalities and precancerous lesions of the penis. Scand. J. Urol. Nephrol. 205 (Suppl), 215-219.
4. Cubilla A.L., Piris A., Pfanni R., Rodriguez I., Aguero F. and Young R.H. (2001). Anatomic levels: important landmarks in penectomy specimens: a detailed anatomic and histologic study based on examination of 44 cases. Am. J. Surg. Pathol. 25, 1091-1094.
5. Dash B.C. and El-Deiry W.S. (2005). Phosphorylation of p21 in G2/M promotes cyclin B-Cdc2 kinase activity. Mol. Cell. Biol. 25, 3364-3387.
6. Doehn C., Baumgartel M. and Jocham D. (2001). Surgical therapy of penis carcinoma. Urologe A 40, 303-307.
7. Eble J.N., Sauter G., Epstein J.I. and Sesterhenn I.A. Ed. (2004). World Health Organization Classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press. Lyon. pp 280-290.
8. Endl E. and Gerdes J. (2000a). The Ki-67 protein: fascinating forms and an unknown function. Exp. Cell Res. 15, 257, 231-237.
9. Endl E. and Gerdes J. (2000b). Posttranslational modifications of the Ki-67 protein coincide with two major checkpoints during mitosis. J. Cell. Physiol. 182, 371-380.
10. Emerson R.E., Ulbright T.M., Eble J.N., Geary W.A., Eckert G.J. and Cheng L. (2001). Predicting cancer progression in patients with penile squamous cell carcinoma: the importance of depth of invasion and vascular invasion. Mod. Pathol. 14, 963-968.
11. Ferreux E., Lont A.P., Horenblas S., Gallee M.P., Raaphorst F.M., von Knebel Doeberitz M., Meiler C.J. and Snijders P.J. (2003). Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J. Pathol. 201, 109-118.
12. Ficarra V., Martignoni G., Maffei N., Cerruto M.A., Novara G., Cavalleri S. and Artibani W. (2002). Predictive pathological factors of lymph nodes involvement in the squamous cell carcinoma of the penis. Int. Urol. Nephrol. 34, 245-250.
13. Gentile V., Vicini P., Giacomelli L., Cardillo M.R., Pierangeli A. and Degener A.M. (2006). Detection of human papillomavirus DNA, p53 and Ki67 expression in penile carcinomas. Int. J. Immunopathol. Pharmacol. 19, 209-215.
14. Giannoudis A. and Herrington CS. (2000). Differential expression of p53 and p21 in low grade cervical squamous intraepithelial lesions infected with low, intermediate, and high risk human papillomaviruses. Cancer 15, 89, 1300-1307.
15. Graflund M., Sorbe B., Sigurdardottir S. and Karlsson M.G. (2004). Relation between HPV-DNA and expression of p53, bcl-2, p21WAF-1, MIB-1, HER-2/neu and DNA ploidy in early cervical carcinoma: correlation with clinical outcome. Oncol. Rep. 12, 169-176.
16. Horenblas S. (2001). Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection. BJU Int. 88, 473-483.
17. Husnjak K., Grce M., Magdic L. and Pavelic K. (2000). Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J. Virol. Methods. 88, 125-134.
18. Kroon B.K., Horenblas S., Lont A.P., Tanis P.J., Gallee M.P. and Nieweg O.E. (2005). Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J. Urol. 173, 816-819.
19. Lazaris A.C., Rigopoulou A., Tseleni-Balafouta S., Kavantzas N., Thimara I., Zorzos H.S., Eutychiadis C.A., Petraki K., Kandiloros D. and Davaris P. (2002). Immunodetection and clinico-pathological correlates of two tumour growth regulators in laryngeal carcinoma. Histol. Histopathol. 17, 131-138.
20. Lont A.P., Kroon B.K., Horenblas S., Gallee M.P., Berkhof J., Meijer C.J. and Snijders P.J. (2006). Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int. J. Cancer. 119, 1078-1081.
21. Lopes A., Hidalgo G.S., Kowalski L.P., Torloni H., Rossi B.M. and Fonseca F.P. (1996). Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J. Urol. 156, 1637-1642.
22. Malanchi I., Accardi R., Diehl F., Smet A., Androphy E., Hoheisel J. and Tommasino M. (2004). Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression. J. Virol. 78, 13769-13778.
23. Martins A.C., Faria S.M., Cologna A.J., Suaid H.J. and Tucci S. Jr (2002). Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J. Urol. 167, 89-92.
24. Matsumoto M., Komiyama K., Okaue M., Shimoyama Y., Iwakami K., Namaki S., Tanaka H., Moro I. and Sato H. (1999). Predicting tumor metastasis in patients with oral cancer by means of the proliferation marker Ki67. J. Oral. Sci. 41, 53-56.
25. Medina Perez M., Valero Puerta J. and Martinez Igarzabal M.J. (1999). Verrucous carcinoma of the penis with intense basal expression of Ki 67. Arch. Esp. Urol. 52, 983-985.
26. Padovan P., Salmaso R., Marchetti M. and Padovan R. (2000). Prognostic value of bcl-2, p53 and Ki-67 in invasive squamous carcinoma of the uterine cervix. Eur. J. Gynaecol. Oncol. 21, 267-272.
27. Poetsch M., Dittberner T. and Woenckhaus C. (2001). PTEN/MMAC1 in malignant melanoma and its importance for tumor progression. Cancer Genet. Cytogenet. 125, 21-26.
28. Protzel C., Knodel J.E., Zimmermann U., Klebingat K.J., Giebel J. and Woenckhaus C. (2004). Strong expression of proliferation marker Ki67 predicts lymph node metastasis in patients with penile cancer. J. Urol. 171 (Suppl), 309.
29. Riethdorf S., Riethdorf L., Milde-Langosch K., Park T.W. and Loning T. (2000). Differences in HPV 16 and HPV 18 E6/E7 oncogene expression between in situ and invasive adenocarcinomas of the cervix uteri. Virchows Arch. 437, 491-500.
30. Rubin M.A., Kleter B., Zhou M., Ayala G., Cubilla A.L., Quint W.G.V. and Pirog E.C. (2001). Detection and typing of human papillomavirus DNA in penile carcinoma. Am. J. Pathol. 159, 1211-1218.
31. Schoeneich G., Perabo F.G.E. and Muller S.C. (1999). Squamous cell carcinoma of the penis. Andrologia 31 (Suppl 1), 17-20.
32. Slaton J.W., Morgenstern N., Levy D.A., Santos M.W. Jr, Tamboli P., Ro J.Y., Ayala A.G. and Pettaway C.A. (2001). Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J. Urol. 165, 1138-1142.
33. Sobin L.H. and Wittekind C. (2002). TNM Classification of malignant tumours. 6th edn. Wiley-Liss. New York. pp 181-183.
34. Solsona E., Iborra I., Rubio J., Casanova J.L., Ricos J.V. and Calabuig C. (2001). Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J. Urol. 165, 1506-1509.
35. Theodorescu D., Russo P., Zhang Z.F., Morash C. and Fair W.R. (1996). Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes. J. Urol. 155, 1626-1631.
36. Thomas M., Pim D. and Banks L. (1999). The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene 18, 7690-7700.
37. Tisell L.E., Oden A., Muth A., Altiparmak G., Molne J., Ahlman H. and Nilsson O. (2003). The Ki67 index a prognostic marker in medullary thyroid carcinoma. Br. J. Cancer 89, 2093-2097.
38. Valente G., Giusti U., Kerim S., Gabriele P., Motta M., Ragona R., Navone R. and Palestro G. (1999). High prognostic impact of growth fraction parameters in advanced stage laryngeal squamous cell carcinoma. Oncol. Rep. 6, 289-293.
39. Villavicencio H., Rubio-Briones J., Regalado R., Chechile G., Algaba F. and Palou J. (1997). Grade, local stage and growth pattern as prognostic factors in carcinoma of the penis. Eur. Urol. 32, 442-447.
40. Xuan Y.H., Choi Y.L., Shin Y.K., Kook M.C., Chae S.W., Park S.M., Chae H.B. and Kim SH. (2005). An immunohistochemical study of the expression of cell-cycle-regulated proteins p53, cyclin D1, RB, p27, Ki67 and MSH2 in gallbladder carcinoma and its precursor lesions. Histol. Histopathol. 20, 59-66.